Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Vanta Bioscience Ltd (NSE: VANTABIO), ISIN INE695X01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VANTABIO last traded at ₹20.58, with a 52-week range of ₹14.71 to ₹29.00 (as of 10 Sep 2026).
Shareholding as of Sep 2025: promoters 72.81%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 63/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.